In this study, we have shown that monitoring serum albumin, AST, and ALT during the febrile phase of illness, in addition to the warning signs detailed in the 2009 WHO guidelines, could enhance the ability to predict the risk of a patient developing severe dengue. This evidence concerns the gene GPT and dengue disease.